Sagimet Biosciences Maintained Market Outperform by Citizens
Citizens maintained Sagimet Biosciences at Market Outperform, cutting the price target to $27.00/share from $29.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.